129 related articles for article (PubMed ID: 22530655)
1. Risk factors for hypertrophic surgical scar development after thyroidectomy.
Kim JH; Sung JY; Kim YH; Lee YS; Chang HS; Park CS; Roh MR
Wound Repair Regen; 2012; 20(3):304-10. PubMed ID: 22530655
[TBL] [Abstract][Full Text] [Related]
2. Early intervention in thyroidectomy scars: demographics, symptoms, and prevention.
Shin JU; Park JH; Oh SH; Jeong JJ; Kang S; Nam K; Chung WY; Lee JH
J Wound Care; 2015 Apr; 24(4):163-4, 166-8, 170-1. PubMed ID: 25853473
[TBL] [Abstract][Full Text] [Related]
3. Evaluating hypertrophic thyroidectomy scar outcomes after treatment with triamcinolone injections and copper bromide laser therapy.
On HR; Lee SH; Lee YS; Chang HS; Park C; Roh MR
Lasers Surg Med; 2015 Aug; 47(6):479-84. PubMed ID: 26149958
[TBL] [Abstract][Full Text] [Related]
4. Perioperative conditions affect long-term hypertrophic scar formation.
van der Veer WM; Ferreira JA; de Jong EH; Molema G; Niessen FB
Ann Plast Surg; 2010 Sep; 65(3):321-5. PubMed ID: 20733369
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Risk Factors to Predict Occurrence and Prognosis of Postsurgical Hypertrophic Scar Development: A Review of 4238 Cases.
Cho MY; Lee SG; Kim JE; Lee YS; Chang HS; Roh MR
Yonsei Med J; 2023 Nov; 64(11):687-691. PubMed ID: 37880850
[TBL] [Abstract][Full Text] [Related]
6. Formation of hypertrophic scars: evolution and susceptibility.
Mahdavian Delavary B; van der Veer WM; Ferreira JA; Niessen FB
J Plast Surg Hand Surg; 2012 Apr; 46(2):95-101. PubMed ID: 22471257
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Hypertrophic Scarring after Thyroidectomy.
Xie H; Xiang Y; Yang E; Zhang H
Adv Skin Wound Care; 2021 Oct; 34(10):1-6. PubMed ID: 34546207
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting hypertrophic scar development in median sternotomy incisions for congenital cardiac surgery.
Nakamura K; Irie H; Inoue M; Mitani H; Sunami H; Sano S
J Am Coll Surg; 1997 Sep; 185(3):218-23. PubMed ID: 9291396
[TBL] [Abstract][Full Text] [Related]
9. Objective and subjective scar aesthetics in minimal access vs conventional access parathyroidectomy and thyroidectomy surgical procedures: a paired cohort study.
O'Connell DA; Diamond C; Seikaly H; Harris JR
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):85-93. PubMed ID: 18209143
[TBL] [Abstract][Full Text] [Related]
10. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons.
Chan HH; Wong DS; Ho WS; Lam LK; Wei W
Dermatol Surg; 2004 Jul; 30(7):987-94; discussion 994. PubMed ID: 15209788
[TBL] [Abstract][Full Text] [Related]
11. Scar perceptions after thyroid and parathyroid surgery: comparison of minimal and conventional approaches.
Linos D; Economopoulos KP; Kiriakopoulos A; Linos E; Petralias A
Surgery; 2013 Mar; 153(3):400-7. PubMed ID: 22980435
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hypertrophic burn scar pain, pruritus, and paresthesia development.
Xiao Y; Sun Y; Zhu B; Wang K; Liang P; Liu W; Fu J; Zheng S; Xiao S; Xia Z
Wound Repair Regen; 2018 Mar; 26(2):172-181. PubMed ID: 29719102
[TBL] [Abstract][Full Text] [Related]
13. Minimal extracorporeal circulation (MECC) does not result in less hypertrophic scar formation as compared to conventional extracorporeal circulation (CECC) with dexamethasone.
Soykan EA; Butzelaar L; de Kroon TL; Beelen RH; Ulrich MM; Mink van der Molen AB; Niessen FB
Perfusion; 2014 May; 29(3):249-59. PubMed ID: 24214029
[TBL] [Abstract][Full Text] [Related]
14. Multimodality scar management program.
Widgerow AD; Chait LA; Stals PJ; Stals R; Candy G
Aesthetic Plast Surg; 2009 Jul; 33(4):533-43. PubMed ID: 19048338
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of nonablative fractional laser versus ablative fractional laser in thyroidectomy scar prevention: A pilot study.
Kim HS; Lee JH; Park YM; Lee JY
J Cosmet Laser Ther; 2012 Apr; 14(2):89-93. PubMed ID: 22409153
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefits in endoscopic thyroidectomy by the axillary approach.
Ikeda Y; Takami H; Sasaki Y; Takayama J; Niimi M; Kan S
J Am Coll Surg; 2003 Feb; 196(2):189-95. PubMed ID: 12595044
[TBL] [Abstract][Full Text] [Related]
17. Completion thyroidectomy for malignancy after initial minimal access thyroid surgery.
Yeh MW; Sidhu SB; Sywak M; Edhouse P; Delbridge LW
ANZ J Surg; 2006 May; 76(5):332-4. PubMed ID: 16768692
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hypertrophic scar formation and its characteristics among the Chinese population.
Li-Tsang CW; Lau JC; Chan CC
Burns; 2005 Aug; 31(5):610-6. PubMed ID: 15993306
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series.
Zouboulis CC; Blume U; Büttner P; Orfanos CE
Arch Dermatol; 1993 Sep; 129(9):1146-51. PubMed ID: 8363398
[TBL] [Abstract][Full Text] [Related]
20. [A study on the expressions and the correlation of TGF-beta and alpha-SMA in scars].
Tian Y; Tang S; Luo S
Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):75-7. PubMed ID: 11593622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
